At a glance
ClinicalIndex Comparison RecordN/ACompleted· 49 enrolled
Drug / intervention
Oxalert Monitor Mode +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wearable Device for Prevention of Opioid-Induced Hypoxemia
In Brief
An observational study evaluating Oxalert Monitor Mode and Oxalert Normal mode for Non-cardiac Surgery. Completed, enrolled 49 participants across 1 site.
Detailed Summary
To evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon-cardiac Surgery
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
First PostedJul 2020
Primary CompletionApr 2022
Study CompletionJun 2023
TodayJul 2026
First PostedJul 1, 2020
Enrollment StartJun 26, 2020
Primary CompletionApr 30, 2022
Study CompletionJun 15, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.0 years ago
Interventions
Oxalert Monitor Modedevice
The investigator will evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO. Using the Oxalert in monitor only mode.
Oxalert Normal modedevice
The investigator will evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO using the Oxalert in monitor in normal mode